Methyldopa Bristol Laboratories (Anhydrous Methyldopa)

Methyldopa is converted in the central nervous system to alpha‑methylnorepinephrine, which activates alpha‑2 adrenergic receptors in the brainstem. This activation reduces sympathetic outflow, decreasing norepinephrine release and lowering peripheral vascular resistance, resulting in a gradual reduction of systemic arterial pressure.

The appropriate dose of Methyldopa is individualized and must be determined by a qualified prescriber. Dosage depends on factors such as the severity of hypertension, patient age, renal function, and response to therapy, and should follow the prescribing information provided by the healthcare professional.

Methyldopa is classified as a medication that can be used during pregnancy when the benefits outweigh potential risks, making it a common choice for pregnancy‑induced hypertension. Limited data are available for breastfeeding; therefore, a healthcare provider should evaluate the risk‑benefit profile before use in lactating women.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with many newer antihypertensives, Methyldopa has a slower onset of action and is less likely to cause rapid blood‑pressure fluctuations. Its central mechanism makes it especially useful in pregnancy, whereas other classes such as ACE inhibitors or calcium‑channel blockers may be contraindicated or less studied in that population.

Methyldopa tablets should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Methyldopa is taken orally, usually with or without food, as directed by a healthcare professional. The tablets are swallowed whole with a glass of water, and the dosing schedule is tailored to the individual’s blood‑pressure targets and tolerability.

Serious adverse events, although rare, include liver dysfunction, hemolytic anemia, and lupus‑like syndrome. Patients should be advised to report symptoms such as jaundice, dark urine, unexplained fatigue, rash, or joint pain promptly, as these may indicate a need for immediate medical evaluation.

Methyldopa is contraindicated in individuals with known hypersensitivity to the drug or any of its components. Caution is also advised for patients with severe cardiovascular disease, liver impairment, or a history of autoimmune disorders, and it should be avoided in those taking certain interacting medications without medical supervision.